These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21749843)

  • 1. Varenicline induces manic relapse in bipolar disorder.
    Knibbs N; Tsoi DT
    Gen Hosp Psychiatry; 2011; 33(6):641.e1-2. PubMed ID: 21749843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varenicline (champix)-associated manic relapse in bipolar affective disorder.
    MacSuibhne S; Giwa TA; McCauley MD
    Ir Med J; 2010 Oct; 103(9):286. PubMed ID: 21186758
    [No Abstract]   [Full Text] [Related]  

  • 3. Varenicline (Chantix) warnings: risk versus benefit.
    Med Lett Drugs Ther; 2008 Jul; 50(1290):53. PubMed ID: 18617873
    [No Abstract]   [Full Text] [Related]  

  • 4. A manic episode in a 64-year-old man: an adverse effect of varenicline.
    Ahmed AI
    Gen Hosp Psychiatry; 2011; 33(2):200.e9-200.e11. PubMed ID: 21596218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varenicline for tobacco dependence.
    Cantrell MA; Geraets D
    N Engl J Med; 2009 Feb; 360(7):730-1. PubMed ID: 19213691
    [No Abstract]   [Full Text] [Related]  

  • 6. Varenicline induced mania in a 51 year old patient without history of bipolar illness.
    Hussain S; Kayne E; Guwanardane N; Petrides G
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1162-3. PubMed ID: 21396974
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of nicotine dependence with Chantix (varenicline).
    Rankin KV; Jones DL
    Tex Dent J; 2011 May; 128(5):457-61. PubMed ID: 21834368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of late-life onset mania during Varenicline assisted smoking cessation.
    Francois D; Odom A; Kotbi N
    Int J Geriatr Psychiatry; 2011 Jun; 26(6):658-9. PubMed ID: 21480382
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission.
    Lyon GJ
    J Clin Psychopharmacol; 2008 Dec; 28(6):720-1. PubMed ID: 19011454
    [No Abstract]   [Full Text] [Related]  

  • 10. Varenicline (Chantix) for tobacco dependence.
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):66-8. PubMed ID: 16977281
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness and safety of varenicline for smoking cessation].
    Christalla P; Dewenter M; El-Armouche A
    Dtsch Med Wochenschr; 2012 May; 137(18):940-4. PubMed ID: 22492478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varenicline and the evaluation of neuropsychiatric adverse events in smokers.
    O'Malley SS
    Biol Psychiatry; 2011 Jun; 69(11):1017-8. PubMed ID: 21550436
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
    Garza D; Murphy M; Tseng LJ; Riordan HJ; Chatterjee A
    Biol Psychiatry; 2011 Jun; 69(11):1075-82. PubMed ID: 21295286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline for tobacco dependence.
    Tavares AR
    N Engl J Med; 2009 Feb; 360(7):731. PubMed ID: 19222131
    [No Abstract]   [Full Text] [Related]  

  • 15. Practical implementation of varenicline as an aid to smoking cessation in clinical practice.
    Tonstad S
    Pneumologia; 2009; 58(3):167-74. PubMed ID: 19817313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse neuropsychiatric events associated with varenicline use in veterans: a case series.
    Cantrell M; Argo T; Haak L; Janney L
    Issues Ment Health Nurs; 2012 Oct; 33(10):665-9. PubMed ID: 23017042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In brief: Cardiovascular safety of varenicline (Chantix).
    Med Lett Drugs Ther; 2011 Aug; 53(1371):65. PubMed ID: 21860367
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
    Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline for smoking cessation.
    Tonstad S
    Expert Rev Neurother; 2007 Feb; 7(2):121-7. PubMed ID: 17286546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.